Race Oncology Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RAONF research report →
Price Chart
About the company
Based in Sydney, Australia, Race Oncology Limited is an Australian precision oncology firm that commenced operations in 2011. The company's primary focus is the development of Zantrene, a potent small molecule designed to inhibit the fatso/fat mass and obesity associated protein (FTO). This therapeutic agent is currently in Phase II/III clinical trials, exploring its potential to treat a range of cancers, including melanoma, clear cell renal cell carcinoma, acute myeloid leukaemia, breast cancer, and ovarian cancer.
- CEO
- Daniel Tillett
- IPO
- 2021
- HQ
- Sydney, NSW, AU
Get TickerSpark's AI analysis on RAONF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $451.73M
- P/E
- -38.26
- PEG
- 0.43
- P/S
- 514.78
- P/B
- 15.45
- EV/EBITDA
- -37.44
- Div Yield
- 0.00%
- Gross Margin
- 49.76%
- Op Margin
- -1294.94%
- Net Margin
- -1190.78%
- ROE
- -47.44%
- ROIC
- -33.36%
Latest fiscal year · YoY change
- Revenue
- $6.04M+51.0%
- Gross Profit
- $5.41M+143.3%
- Op Income
- $-3,771,834
- Net Income
- $-4,787,258+65.4%
- EPS
- $-0.03+66.9%
- OCF Growth
- +52.1%
- FCF Growth
- +52.1%
- 52W High
- $2.60
- 52W Low
- $0.83
- 50D MA
- $1.22
- 200D MA
- $1.22
- Beta
- 1.91
- RSI (14)
- 0
- Avg Volume
- 1
No earnings-call transcripts are available for RAONF yet.
- Free Float
- 69.7%
- Shares Outstanding
- 173.74M
- Float Shares
- 121.18M
Our RAONF coverage
Recent articles, reports, and earnings notes.
No research on RAONF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RAONF report →October inflation, jobs reports cancelled due to US government shutdown
proactiveinvestors.com · Nov 21
Fed may skip December cut but leave door open for January, Deutsche Bank analysts say
proactiveinvestors.com · Nov 21
Race Oncology launches new clinical programs in AML and lung cancer
proactiveinvestors.com · Nov 17
Pensana shares up as it launches new drill and testing plans for Angola rare-earth project
proactiveinvestors.com · Nov 17
Race Oncology makes significant quarterly progress in Phase 1 RC220 trial
https://www.proactiveinvestors.com · Jan 31
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.